Pharming (PHAR) Research & Development (2020 - 2026)
Pharming (PHAR) reported Research & Development of -$57.82 million for Q2 2026, compared with -$44.84 million a year earlier.
Powered by 
Analysis
Pharming (PHAR) Research & Development (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Pharming's Research & Development came in at -$111.26 million; for FY2025, it came in at $100.4 million, up 20.7% from FY2024.
- By year, Research & Development came in at $83.15 million in FY2024 (+20.7%), $68.91 million in FY2023, -$52.53 million in FY2022 and -$70.37 million in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Research & Development in data going back to Q3 2020.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$25.56 million (Q1 2026), -$4.48 million (Q4 2025) and -$23.4 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Pharming | 664.67 Mn | -129.70 Mn | 141.47 Mn | -57.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -57.82 Mn |
| Mar 31, 2026 | -25.56 Mn |
| Dec 31, 2025 | -32.10 |
| Sep 30, 2025 | -23.40 Mn |
| Jun 30, 2025 | -44.84 Mn |
| Mar 31, 2025 | -21.10 Mn |
| Dec 31, 2024 | -22.30 |
| Sep 30, 2024 | -20.70 Mn |
| Jun 30, 2024 | -40.12 Mn |
| Mar 31, 2024 | -18.50 Mn |
| Dec 31, 2023 | -11.60 Mn |
| Sep 30, 2023 | -20.75 Mn |
| Jun 30, 2023 | -20.90 Mn |
| Mar 31, 2023 | -15.62 Mn |
| Dec 31, 2022 | -10.90 Mn |
| Sep 30, 2022 | -12.30 Mn |
| Dec 31, 2021 | 70.44 Mn |
| Sep 30, 2021 | -13.32 Mn |
| Dec 31, 2020 | 68.58 Mn |
| Sep 30, 2020 | -9.13 Mn |
API Access
Pharming Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=PHAR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "PHAR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=PHAR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();